aTYR PHARMA INC Uncategorized Contracts & Agreements
11 Contracts & Agreements
- Amendment No. 1 to Open Market Sale Agreement, dated December 23, 2024, by and among aTyr Pharma, Inc. and Jefferies LLC (Filed With SEC on December 23, 2024)
- aTyr Pharma, Inc. 2022 Inducement Plan (Filed With SEC on May 10, 2022)
- Open Market Sale AgreementSM, dated April 22, 2022, by and between aTyr Pharma, Inc. and Jefferies LLC (Filed With SEC on April 22, 2022)
- Strategic Advisor Agreement, dated November 1, 2017, by and between the Company and John D. Mendlein, Ph.D (Filed With SEC on November 14, 2017)
- aTyr Pharma, Inc. 3545 John Hopkins Court, Suite #250 San Diego CA 92121 Phone ###-###-#### (Filed With SEC on March 16, 2017)
- aTyr Pharma, Inc. 3545 John Hopkins Court, Suite #250 San Diego CA 92121 Phone ###-###-#### Fax ###-###-#### (Filed With SEC on March 16, 2017)
- aTyr Pharma, Inc. 3565 General Atomics Court Suite 103 San Diego CA 92121 Phone ###-###-#### Fax ###-###-#### (Filed With SEC on March 30, 2016)
- aTyr Pharma, Inc. 3565 General Atomics Court Suite 103 San Diego CA 92121 Phone ###-###-#### Fax ###-###-#### (Filed With SEC on March 30, 2016)
- * Confidential Information,indicated by [***], has been omitted from this filing and filed separately with the Securities and Exchange Commission Page 1 of 27 (Filed With SEC on August 12, 2015)
- ATYR PHARMA, INC. 2014STOCK PLAN (Filed With SEC on April 27, 2015)
- ATYR PHARMA, INC. 2014STOCK PLAN (Filed With SEC on April 6, 2015)
